Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRSP compared with BLSH: revenue, margins and what each company keeps, and the suppliers and customers both name
CRSP
CRISPR Therapeutics AG
Change
Mkt cap
Revenue
Revenue
BLSH
Bullish
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRSP
CRISPR Therapeutics AG
vs
BLSH
Bullish
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
CRSP
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.7%
0.00%
×0.00
Q2 FY26
±7.8%
▲
+7.06%
×0.91
Q1 FY26
±5.9%
▼
−2.24%
×0.37
Feb 13 '26
±3.6%
▲
+8.46%
×2.36
BLSH
No earnings history for BLSH.
= implied
CRSP realized, solid
BLSH realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
CRSP
CRISPR Therapeutics AG
Change
50.08
▲
+3.13%
· post 50.00
Mkt cap
$4.9B
Revenue
$13M
Q3 FY26
Revenue
$4M
FY25
BLSH
Bullish
Change
21.32
▲
+2.95%
· post 21.37
Closed
Nov 6 '26
Mkt cap
$3.2B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
CRSP
CRISPR Therapeutics AG
vs
BLSH
Bullish
50.08
▲
+3.13%
post 50.00
Price
21.32
▲
+2.95%
post 21.37
$4.9B
Mkt cap
$3.2B
Q3 FY26
$13M
Revenue
—
FY25
$4M
Revenue
—
Change
Change
CRSP
50.08
▲
+3.13%
vs
BLSH
21.32
▲
+2.95%
Closed
Nov 6 '26